Skip to main content
Srinivas Vourganti, MD, Urology, Chicago, IL, Rush University Medical Center

SrinivasVourgantiMD

Urology Chicago, IL

Minimally Invasive Surgery, Stone Disease, Surgical Oncology

Assistant Professor of Urology, Urologic Oncology, Rush University Medical Center

Dr. Vourganti is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Vourganti's full profile

Already have an account?

  • Office

    1725 W Harrison St
    Suite 970, Professional Office Bldg III
    Chicago, IL 60612
    Phone+1 312-563-3447
    Fax+1 312-563-3721
  • Is this information wrong?

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Minimally Invasive Urologic Surgery, 2010 - 2013
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Urology, 2006 - 2010
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Urology, 2006 - 2007
  • Case Western Reserve University/University Hospitals Cleveland Medical Center
    Case Western Reserve University/University Hospitals Cleveland Medical CenterResidency, Surgery, 2004 - 2006
  • Ohio State University College of Medicine
    Ohio State University College of MedicineClass of 2004
  • University of Michigan
    University of MichiganBS, Cellular and Molecular Biology, 1994 - 1998
  • Regents of The University of Michigan - Regional Alliance for HEA
    Regents of The University of Michigan - Regional Alliance for HEAB.S., Cellular and Molecular Biology, With honors, 1994 - 1998

Certifications & Licensure

  • IL State Medical License
    IL State Medical License 2016 - 2026
  • NY State Medical License
    NY State Medical License 2013 - 2016
  • VA State Medical License
    VA State Medical License 2010 - 2014
  • OH State Medical License
    OH State Medical License 2004 - 2010
  • American Board of Urology Urology

Awards, Honors, & Recognition

  • Winning Abstract, "Treatment of Epstein-Barr Virus Transformed B-Cell Lines with the Histone Deacetylase Inhibitor Depsipeptide (FR901228) Results in the Induction of a Viral Thymidine Kinase and Enhanced Susceptibility to Antiviral-Induced Apoptosis" American College of Physicians, 2002
  • Winner Poster, "MRI Fusion Prostate Biopsy Outperforms 12-Core Systeatic Prostate Biopsy in Patients With Prior Negative Biopsy History: A Multi-institutional Analysis" American Urologic Association, 2016
  • Urology Medical Student Faculty Teaching Award SUNY Upstate, 2015
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Lack of Impact of Robotic Assisted Laparoscopic Radical Prostatectomy on Intraoperative Levels of Prostate Cancer Circulating Tumor Cells  
    Kauffman EC, Lee MJ, Alarcon SV, Lee S, Hoang AN, Walton Diaz A, Chelluri R, Vourganti S, Trepel JB, Pinto PA, Journal of Urology, 1/1/2016
  • Chromophobe Renal Cell Carcinoma Is the Most Common Nonclear Renal Cell Carcinoma in Young Women: Results from the SEER Database  
    Daugherty M, Blakely S, Shapiro O, Vourganti S, Mollapour M, Bratslavsky G, Journal of Urology, 1/1/2016
  • Pannus Is the New Prepuce? Penile Cancer in a Buried Phallus  
    Manwaring J, Vourganti S, Nikolavsky D, Valente AL, Byler T, Case Reports in Urology, 1/1/2015
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • High rates of metastatic disease in prostate cancer among BRCA2 mutation carriers: implications for screening
    Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
  • Multi-institutional Assessment of Multiparametric MRI and Fusion Biopsy of the Prostate in a Biopsy-Naïve Population
    Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
  • MRI Fusion Prostate Biopsy Outperforms 12-Core Systeatic Prostate Biopsy in Patients With Prior Negative Biopsy History: A Multi-institutional Analysis
    Vourganti S, American Urologic Association National Meeting, San Diego, CA, 1/1/2016
  • Join now to see all

Lectures

  • Master Class: Prostate Cancer Biopsies – Current Concepts 
    Buenos Aires, Argentina - 1/1/2016
  • Debate: Ultrasound-MRI Fusion Guided Biopsy vs. Transperineal Approach 
    Buenos Aires, Argentina - 1/1/2016
  • MR/US Fusion-Guided Prostate Biopsy: Beginner and Advanced Techniques 
    Chicago, IL - 1/1/2016
  • Join now to see all

Other

Authored Content

  • Fusion Prostate Biopsy Outperforms 12-Core Systematic Prostate Biopsy in Patients with Prior Negative Systematic Biopsy: A Multi-Institutional AnalysisMay 2018

Press Mentions

  • Protect Your Bladder: Quit Smoking
    Protect Your Bladder: Quit SmokingNovember 18th, 2020
  • Could ‘Breast Cancer Genes’ Play Role in Prostate Cancer, Too?
    Could ‘Breast Cancer Genes’ Play Role in Prostate Cancer, Too?May 9th, 2016
  • Mutations May Play Role in Prostate Cancer
    Mutations May Play Role in Prostate CancerMay 12th, 2016

Hospital Affiliations